Logo

American Heart Association

  2
  0


Final ID: MDP1748

An Innovative, Non-invasive, Credit-Card Sized Device for Ambulatory 12 Lead ECG Recording: First-In-Human Experience Compared to Standard 12 Lead ECG

Abstract Body (Do not enter title and authors here): Background: The multiple electrodes needed to generate a 12-lead electrocardiogram (12L ECG) limits its use to traditional health care settings. An innovative credit-card sized unit (HeartBeam, Santa Clara, CA, USA) when placed on the chest without cables captures a vectorcardiogram (VCG). A personalized transformation matrix (PTM) then converts the signals into a 12L ECG.

Objective: This is the first quantitative (standard intervals and amplitudes) and qualitative (rhythm diagnosis) accuracy assessment of a synthesized 12L ECG (Syn 12L) compared to a simultaneously recorded standard 12L ECG (Std 12L) on patients in sinus rhythm (SR) or in a non-life-threatening arrhythmia.

Methods: The 80 patients, who were enrolled at a single center (Dedinje Cardiovascular Research Institute, Belgrade, Serbia), first underwent recording of a Std 12L and VCG to create a unique PTM, which was used to create the Syn 12L from the VCG. Then a simultaneous Std 12L and VCG were recorded. The quantitative endpoint was the calculated difference (mean and standard deviation [SD]) between the Syn 12L and Std 12L in a series of intervals (RR, PQ, QJ, and QT) and amplitudes (P wave, R wave, and T wave). For the qualitative endpoint, 2 blinded electrophysiology physicians (EP) classified the Syn 12L and Std 12L arrhythmia status.

Results: Of the 80 patients, 41 were in SR and 39 in another rhythm (3:SR with PACs, 5:SR with PVCs, 1:SR with pre-excitation, 16:atrial fibrillation, 3:atrial flutter, 2:atrial pacing, and 9:ventricular pacing). The interval and amplitude differences are listed in the table. Rhythm classification by the blinded EPs demonstrated a sensitivity of 94.9% (95% CI: 82.7-99.4%) and specificity of 100% (95% CI: 91.4-100%) compared to Std 12L.

Conclusion: In this first study comparing the performance of a 12L ECG created from a credit card sized VCG recorder, the 12L Syn demonstrated clinically equivalent interval and amplitude accuracy and excellent agreement in arrhythmia classification when compared to a simultaneously recorded 12L Std. This approach holds significant promise, potentially permitting patients to obtain a 12L ECG outside of a health care setting with a compact, easy to use device.
  • Deering, Thomas  ( Piedmont Heart Institute , Atlanta , Georgia , United States )
  • Vukajlovic, Dejan  ( Dedinje Cardiovascular Research Institute , Belgrade , Serbia )
  • Babic, Milos  ( Dedinje Cardiovascular Research Institute , Belgrade , Serbia )
  • Djurdjevic, Branko  ( Dedinje Cardiovascular Research Institute , Belgrade , Serbia )
  • Atanasoski, Vladimir  ( HeartBeam Inc. , Santa Clara , California , United States )
  • Miletic, Marjan  ( HeartBeam Inc. , Santa Clara , California , United States )
  • Mittal, Suneet  ( Valley Health System , Paramus , New Jersey , United States )
  • Sanders, Prashanthan  ( University of Adelaide , Adelaide , South Australia , Australia )
  • Author Disclosures:
    Thomas Deering: DO have relevant financial relationships ; Speaker:Sanofi:Past (completed) ; Speaker:Pfizer:Past (completed) ; Speaker:AltaThera:Past (completed) ; Consultant:HeartBeam:Active (exists now) ; Consultant:Preventice:Active (exists now) ; Other (please indicate in the box next to the company name):Abbott: Clinical Study Review Committee:Past (completed) ; Consultant:PaceMate:Active (exists now) ; Consultant:CVRx:Past (completed) ; Researcher:Milestone:Past (completed) | Dejan Vukajlovic: No Answer | Milos Babic: No Answer | Branko Djurdjevic: DO NOT have relevant financial relationships | Vladimir Atanasoski: DO have relevant financial relationships ; Consultant:HeartBeam inc:Active (exists now) ; Individual Stocks/Stock Options:HeartBeam inc:Active (exists now) | Marjan Miletic: DO NOT have relevant financial relationships | Suneet Mittal: No Answer | Prashanthan Sanders: DO have relevant financial relationships ; Advisor:Medtronic:Active (exists now) ; Research Funding (PI or named investigator):Medtronic:Active (exists now) ; Research Funding (PI or named investigator):Abbott :Active (exists now) ; Research Funding (PI or named investigator):Boston Scientific:Active (exists now) ; Advisor:Pacemate:Active (exists now) ; Advisor:CathRx:Active (exists now) ; Advisor:Abbott :Active (exists now) ; Advisor:Boston Scientific:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Pushing the Boundaries: Innovations in Electrophysiology

Monday, 11/18/2024 , 11:10AM - 12:25PM

Moderated Digital Poster Session

More abstracts on this topic:
Americans’ Views on Healthcare Coverage, Access, and Equity in the US: Implications for Cardiovascular Health

Perera Sudheesha, Wadhera Rishi, Khullar Dhruv

Artificial Intelligence Assessment of Diastolic Dysfunction by Electrocardiogram: Outcomes in Cardiac Intensive Care Unit Patients

Hillerson Dustin, Jentzer Jacob, Lee Eunjung, Attia Zachi, Kane Garvan, Lopez-jimenez Francisco, Noseworthy Peter, Friedman Paul, Oh Jae

More abstracts from these authors:
A Personal Risk Assessment Device in Patients with Chest Pain

Shvilkin Alexei, Zlatic Natasa, Atanasoski Vladimir, Grujovic Zdolsek Sanja, Popovic Maneski Lana, Miletic Marjan, Vukcevic Vladan

Artificial Intelligence-based improvement of smartwatch detection of AF

Wan Elaine, Glotzer Taya, Mittal Suneet, Senepart Oceane, Lefebvre Baptiste

You have to be authorized to contact abstract author. Please, Login
Not Available